Pre-treatment shyness mindset predicts less reduction of social anxiety during exposure therapy

被引:16
|
作者
Valentiner, David P. [1 ]
Jencius, Simon
Jarek, Eva [1 ]
Gier-Lonsway, Stephanie L. [1 ]
McGrath, Patrick B.
机构
[1] No Illinois Univ, De Kalb, IL 60115 USA
关键词
Implicit theories; Shyness; Exposure therapy; Social anxiety disorder; IMPLICIT THEORIES; BELIEFS; PERFORMANCE; VALIDATION;
D O I
10.1016/j.janxdis.2013.02.013
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
This study examined the moderating role of shyness mindset on the reduction of social anxiety during exposure-based treatment. Participants (N = 60) in an intensive outpatient program for anxiety disorders were assessed at pre- and post-treatment. Social performance anxiety decreased dramatically during treatment, but the amount of decrease differed as a function of pre-treatment shyness mindset. At one standard deviation above the mean on both the social performance anxiety and shyness mindset measures, an average reduction of 15 points on the social performance anxiety measure was observed. At one standard deviation above the mean on the social performance anxiety measure and one standard deviation below the mean on the shyness mindset measure, an average reduction of 27 points on the social performance anxiety measure was observed. These results suggest that targeting shyness mindset during exposure-based treatments for social anxiety disorder might increase the effectiveness of treatment for individuals with a high shyness mindset.. Published by Elsevier Ltd.
引用
收藏
页码:267 / 271
页数:5
相关论文
共 50 条
  • [31] ASMA predicts for pre-treatment liver biopsy and delays normalisation of ALT during the first 12 weeks of therapy with pegylated interferon and ribavirin but has no impact on SVR
    Lim, Eu Jin
    Clements, Amy E.
    Lubel, John S.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 85 - 85
  • [32] ACTIGRAPHY-BASED PRE-TREATMENT NAP TIME PREDICTS QUALITY OF LIFE DURING CHEMOTHERAPY IN BREAST CANCER PATIENTS
    Liu, L.
    Natarajan, L.
    He, F.
    Johnson, S.
    Parker, B. A.
    Sadler, G. R.
    Mills, P. J.
    Dimsdale, J. E.
    Ancoli-Israel, S.
    [J]. SLEEP, 2009, 32 : A323 - A323
  • [33] The Course of the Working Alliance during Virtual Reality and Exposure Group Therapy for Social Anxiety Disorder
    Ngai, Irene
    Tully, Erin C.
    Anderson, Page L.
    [J]. BEHAVIOURAL AND COGNITIVE PSYCHOTHERAPY, 2015, 43 (02) : 167 - 181
  • [34] Reduction of depersonalization during social stress through cognitive therapy for social anxiety disorder: A randomized controlled trial
    Schweden, Tabea L. K.
    Pittig, Andre
    Brauer, David
    Klumbies, Elisabeth
    Kirschbaum, Clemens
    Hoyer, Juergen
    [J]. JOURNAL OF ANXIETY DISORDERS, 2016, 43 : 99 - 105
  • [35] PRE-TREATMENT ANXIETY AND DEPRESSION LEVELS ARE CORRELATED WITH LESS IMPROVEMENT IN SELF-REPORTED DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGICAL THERAPY: RESULTS FROM THE BRAGGSS COHORT
    Dyball, Sarah
    Cordingley, Lis
    Isaacs, John D.
    Wilson, Gerry
    Morgan, Ann
    Hyrich, Kimme
    Plant, Darren
    Barton, Anne
    [J]. RHEUMATOLOGY, 2018, 57
  • [36] IMMUNOHISTOCHEMISTRY EVALUATION ON PRE-TREATMENT TUMOR TISSUE PREDICTS TREATMENT RESPONSE TO MN-166 (IBUDILAST) AND TEMOZOLOMIDE COMBINATION THERAPY IN GLIOBLASTOMA PATIENTS
    Lathia, Justin
    Lauko, Adam
    Matsuda, Kazuko
    Makhay, Malath
    Nayak, Lakshmi
    Chukwueke, Ugonma
    Lee, Eudocia
    Reardon, David
    Beroukhim, Rameen
    Batchelor, Tracy
    Aquilanti, Elisa
    Wen, Patrick
    [J]. NEURO-ONCOLOGY, 2023, 25
  • [37] PRE-TREATMENT DSA TITER PREDICTS THE EFFECTIVENESS OF CARFILZOMIB-BASED THERAPY FOR ANTIBODY MEDIATED REJECTION IN LUNG TRANSPLANT RECIPIENTS
    Zeevi, Adriana
    Marrari, Marilyn
    Mangiola, Massimo
    Morrell, Matthew R.
    Yousem, Samuel A.
    Pilewski, Joseph M.
    D'Cunha, Jonathan
    McDyer, John F.
    Ensor, Christopher R.
    [J]. HUMAN IMMUNOLOGY, 2016, 77 : 78 - 78
  • [38] Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma
    Strati, Paolo
    Ahmed, Mohamed Amin
    Fowler, Nathan H.
    Nastoupil, Loretta J.
    Samaniego, Felipe
    Fayad, Luis E.
    Hagemeister, Fredrick B.
    Romaguera, Jorge E.
    Rodriguez, Alma
    Wang, Michael
    Westin, Jason R.
    Cheah, Chan
    Noorani, Mansoor
    Feng, Lei
    Davis, Richard E.
    Neelapu, Sattva S.
    [J]. HAEMATOLOGICA, 2020, 105 (07) : 1907 - 1913
  • [39] Reduction of sludge formed during a coagulation treatment of Ridomil Gold by means of non-thermal quenched plasma pre-treatment
    Doringar Tadom
    Georges Kamgang-Youbi
    Elie Acayanka
    Estella Njoyim-Tamungang
    Samuel Laminsi
    [J]. Environmental Monitoring and Assessment, 2018, 190
  • [40] Reduction of sludge formed during a coagulation treatment of Ridomil Gold by means of non-thermal quenched plasma pre-treatment
    Tadom, Doringar
    Kamgang-Youbi, Georges
    Acayanka, Elie
    Njoyim-Tamungang, Estella
    Laminsi, Samuel
    [J]. ENVIRONMENTAL MONITORING AND ASSESSMENT, 2018, 190 (07)